Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMY | AMGN | GILD | ||
| Company | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 56.22 | 269.00 | 90.92 | ||
| High | 57.33 | 269.61 | 93.29 | ||
| Low | 56.08 | 262.21 | 90.71 | ||
| Last | 57.33 | 263.38 | 92.57 | ||
| Change | +1.03 | +2.19 | +1.48 | ||
| % Change | +1.83% | +0.84% | +1.62% | ||
| Volume | 48,212,000 | 13,687,900 | 22,530,100 | ||
| 20-Day Average Volume | 11,813,050 | 5,160,835 | 7,592,390 | ||
| Previous Close | 56.30 | 261.19 | 91.09 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 57.98 | 275.02 | 91.97 | ||
| 20-Day Raw Stochastic | 40.60% | 22.90% | 62.18% | ||
| 20-Day Relative Strength | 52.59% | 32.27% | 55.07% | ||
| Weighted Alpha | +17.93 | -14.54 | +25.30 | ||
| Today's Opinion | 80% Buy | 88% Sell | 100% Buy | ||
| Previous Opinion | 80% Buy | 88% Sell | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 40% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.78% since 12/13/24 | -2.68% since 12/13/24 | +0.78% since 12/13/24 | ||
| Low | 55.68 on 12/16/24 | 253.30 on 12/19/24 | 90.27 on 12/19/24 | ||
| High | 58.54 on 12/18/24 | 272.69 on 12/16/24 | 93.59 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | -0.95% since 11/20/24 | -8.51% since 11/20/24 | +4.45% since 11/20/24 | ||
| Low | 55.04 on 12/13/24 | 253.30 on 12/19/24 | 88.07 on 11/21/24 | ||
| High | 60.68 on 11/25/24 | 297.32 on 11/25/24 | 94.65 on 12/11/24 | ||
| 3-Month | |||||
| %Chg | +16.03% since 09/20/24 | -21.93% since 09/20/24 | +10.28% since 09/20/24 | ||
| Low | 49.11 on 09/25/24 | 253.30 on 12/19/24 | 81.83 on 09/26/24 | ||
| High | 61.08 on 11/11/24 | 339.17 on 09/23/24 | 98.90 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +39.69% since 06/20/24 | -15.01% since 06/20/24 | +35.16% since 06/20/24 | ||
| Low | 39.35 on 07/05/24 | 253.30 on 12/19/24 | 66.01 on 07/05/24 | ||
| High | 61.08 on 11/11/24 | 346.85 on 07/25/24 | 98.90 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 116,275,392 | 141,575,456 | 115,366,840 | ||
| Shares Outstanding, K | 2,028,177 | 537,533 | 1,246,266 | ||
| Annual Sales | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | ||
| Annual Net Income | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | ||
| Last Quarter Sales | 11,892,000,000 | 8,503,000,000 | 7,545,000,000 | ||
| Last Quarter Net Income | 1,211,000,000 | 2,830,000,000 | 1,253,000,000 | ||
| 60-Month Beta | 0.45 | 0.55 | 0.18 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.80 on 10/31/24 | 5.58 on 10/30/24 | 2.02 on 11/06/24 | ||
| Latest Earnings Date | 02/06/25 | 02/04/25 | 02/11/25 | ||
| Most Recent Dividend | 0.600 on 10/04/24 | 2.250 on 11/18/24 | 0.770 on 12/13/24 | ||
| Next Ex-Dividends Date | 01/03/25 | 02/14/25 | 12/13/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 48.12 | 13.59 | 20.56 | ||